AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2015
Jul 31, 2015
29755_dirs_2015-07-31_69908563-e734-4588-8638-ab11f41f581a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-07-29
Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-03 | Common stock, $0.01 par value | G | 8960 | — | Disposed | 473187 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | M | 65000 | $35.88 | Acquired | 538187 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 758 | $71.00 | Disposed | 537429 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 200 | $71.02 | Disposed | 537229 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 1300 | $71.03 | Disposed | 535929 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 700 | $71.04 | Disposed | 535229 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 100 | $71.045 | Disposed | 535129 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 1800 | $71.05 | Disposed | 533329 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 2300 | $71.06 | Disposed | 531029 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 200 | $71.0650 | Disposed | 530829 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 2124 | $71.07 | Disposed | 528705 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 200 | $71.075 | Disposed | 528505 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 2800 | $71.08 | Disposed | 525705 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 100 | $71.085 | Disposed | 525605 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 2500 | $71.09 | Disposed | 523105 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 200 | $71.095 | Disposed | 522905 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 2200 | $71.10 | Disposed | 520705 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 100 | $71.105 | Disposed | 520605 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 1997 | $71.11 | Disposed | 518608 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 200 | $71.115 | Disposed | 518408 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 1700 | $71.12 | Disposed | 516708 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 100 | $71.125 | Disposed | 516608 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 800 | $71.13 | Disposed | 515808 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 500 | $71.14 | Disposed | 515308 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 100 | $71.145 | Disposed | 515208 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 600 | $71.15 | Disposed | 514608 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 500 | $71.155 | Disposed | 514108 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 800 | $71.16 | Disposed | 513308 | Direct |
| 2015-07-29 | Common stock, $0.01 par value | S | 100 | $71.165 | Disposed | 513208 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-29 | Option (right to buy) | $35.88 | M | 65000 | Disposed | 2023-02-13 | Common stock (65000) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4